New Analyses of PSC Data from Phase 2 SPRING Trial Show that Treatment with Nebokitug Is Associated with Dose-Dependent and Significant Improvements in Multiple Inflammatory and Fibrotic Biomarkers Fu ...

Zealand-based soft-tissue repair company Aroa Biosurgery’s share price made gains after reporting its second consecutive ...

Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing efimosfermin alfa, a once-monthly FGF21 analogue for the treatment of metabolic dysfunction-associated steatohepatitis ...

QKS Group, a global leader in strategic innovation advisory, today launched its Most Valuable Pioneers (MVP) initiative, a first-of-its-kind program celebrating organizations that are reshaping ...

Despite the challenges associated with studying exosomes due to their low abundance, small size, and fragility, they are ...